Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
- PMID: 35722609
- PMCID: PMC9186030
- DOI: 10.1136/flgastro-2021-101886
Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
Abstract
The European Association for the Study of the Liver has produced extensive guidelines for the investigation and management of drug-induced liver injury. Here, we provide a commentary and overview of some of the principle disease investigations and management that arise from these guideline recommendations.
Keywords: drug induced hepatotoxicity; drug induced liver injury; drug metabolism; drug toxicity.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: JFD has received research grants and lecture honoraria from MSD, Abbvie and Gilead.
Figures
References
LinkOut - more resources
Full Text Sources